jueves, 7 de marzo de 2019

NHLBI Funding & Research Opportunities and Announcements for February 1, 2019

NHLBI_Standard_Sig_Logo_RGB - New

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

 

Notices

Notice of Information: Report on Site Visits to the Veterans Affairs Medical Centers with Focus on Canine Care and Use in Research
(NOT-OD-19-069) National Institutes of Health
Notice of Special Interest on Methodological Advances to Improve Alcohol Measurement and its Consequences for People Living with HIV who have Comorbidities, Coinfections, and Complications (NOT-AA-19-006) National Institute on Alcohol Abuse and Alcoholism
Notice of NIAID Research Objectives added to PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
(NOT-AI-19-037) National Institute of Allergy and Infectious Diseases
Notice of NIAID Research Objectives added to PAR-18-714 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
(NOT-AI-19-038) National Institute of Allergy and Infectious Diseases
Notice of NCCIH's Participation in PA-19-165, "Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)"
(NOT-AT-19-021) National Center for Complementary and Integrative Health
Notice to Clarify NIBIB's Research Objectives Under PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
(NOT-EB-19-002) National Institute of Biomedical Imaging and Bioengineering
Notice of NHLBI Participation in RFA-TR-19-003 "HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)"
(NOT-HL-19-681) National Heart, Lung, and Blood Institute
Notice of Clarification in Eligibility Requirements for PAR-19-098 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43 Independent Clinical Trial Required)
(NOT-TW-19-002) John E. Fogarty International Center

No hay comentarios: